In Vivo Evaluation of Nanostructured Lipid Carrier Systems (NLCS) in Mice Bearing Prostate Cancer Tumors

Curmumin (CRN)-NLC nanoparticles were administrated to nude mice with LNCaP prostate cancer xenografts and demonstrated substantial tumor volume suppression with no weight loss compared to pure CRN.